Back
4D Molecular Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
FDMT
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
16
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-11.17%
7 Day Trial
ALL ACCESS PASS
$
7
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here4D Molecular Therapeutics Price Quote
$23.21
-0.04 (-1.36%)
(Updated: April 27, 2024 at 4:06 AM ET)
4D Molecular Therapeutics Key Stats
Sell
16
4D Molecular Therapeutics (FDMT)
is a Sell
Day range:
$22.75 - $23.86
52-week range:
$9.44 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
43.81
P/B ratio:
3.76%
Volume:
322.5K
Avg. volume:
663.3K
1-year change:
13.03%
Market cap:
$1.2B
Revenue:
$20.7M
EPS:
$-2.66
How Much Does 4D Molecular Therapeutics Make?
-
How Much Are 4D Molecular Therapeutics's Sales Annually?
FDMT Revenues are $20.7M -
How Much Profit Does 4D Molecular Therapeutics's Make A Year?
FDMT net income is -$100.8M
Is 4D Molecular Therapeutics Growing As A Company?
Data Unavailable
4D Molecular Therapeutics Stock Price Performance
-
Did 4D Molecular Therapeutics Stock Go Up Last Month?
4D Molecular Therapeutics share price went down by -31.72% last month -
Did FDMT's Share Price Rise Over The Last Year?
FDMT share price rose by 13.03% over the past 1 year
What Is 4D Molecular Therapeutics 52-Week High & Low?
-
What Is 4D Molecular Therapeutics’s 52-Week High Share Price?
4D Molecular Therapeutics has traded as high as $36.25 over the past 52 weeks -
What Is 4D Molecular Therapeutics’s 52-Week Low Share Price?
4D Molecular Therapeutics has traded as low as $9.44 over the past 52 weeks
4D Molecular Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy 4D Molecular Therapeutics?
-
How Much Debt Does 4D Molecular Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does 4D Molecular Therapeutics Have?
Cash and short term investments quarterly total is $288.2M -
What Is 4D Molecular Therapeutics’s Book Value Per Share?
Book value per share is 7.15
Is 4D Molecular Therapeutics Cash Flow Positive?
-
What Is FDMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$75.8M -
What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $156.8M -
What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $115.7M
4D Molecular Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FDMT return on invested capital is -35.69% -
What Is 4D Molecular Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -32.32% -
What Is FDMT Return On Equity?
ROE is a measure of profitability and is -35.69%
4D Molecular Therapeutics Earnings Date & Stock Price
-
What Is 4D Molecular Therapeutics's Stock Price Today?
A single share of FDMT can be purchased today for 23.25 -
What Is 4D Molecular Therapeutics’s Stock Symbol?
4D Molecular Therapeutics trades on the nasdaq under the ticker symbol: FDMT -
When Is 4D Molecular Therapeutics’s Next Earnings Date?
The next quarterly earnings date for 4D Molecular Therapeutics is scheduled on May 10, 2024 -
When Is FDMT's next ex-dividend date?
4D Molecular Therapeutics's next ex-dividend date is April 27, 2024 -
How To Buy 4D Molecular Therapeutics Stock?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
4D Molecular Therapeutics Competitors
-
Who Are 4D Molecular Therapeutics's Competitors?
Below is a list of companies who compete with 4D Molecular Therapeutics or are related in some way:
4D Molecular Therapeutics Dividend Yield
Data Unavailable
4D Molecular Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -5.8% |
Revenue: | 0% | -100.79% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 54.22 |
Upside from Last Price: | 133.21% |